Dow Up 0.09% Nasdaq Down 0.02%

Lexicon Pharmaceuticals, Inc. (LXRX)

-NasdaqGS
1.50 Down 0.03(1.96%) 4:00PM EDT
Prev Close:1.53
Open:1.55
Bid:1.50 x 200
Ask:1.54 x 1000
1y Target Est:3.05
Beta:2.47
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:1.49 - 1.55
52wk Range:1.25 - 3.18
Volume:856,115
Avg Vol (3m):1,221,150
Market Cap:772.23M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LXRXDown 1.96%772.23M
DGENDown 1.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):302.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-0.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for human disease. Its drug development programs include LX4211, an orally-delivered small molecule compound that has completed two Phase II clini... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback